NCT Number: NCT00543868
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
This study will determine how if MK0782 is safe and tolerable and to determine how often and the severity of stomach and small intestine ulcers develop following administration of MK0782 plus enteric coated aspirin, rofecoxib 25mg plus enteric coated aspirin, naproxen 500 mg puls enteric coated asprin vs placebo.
This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy male or non pregnant female
- 18 years of age or older (age at consent)
- Able to abstain from alcohol, tobacco, spicy foods, limit coffee
- Able to avoid strenuous activity
- Able to read and fill out a study diary
Exclusion criteria
- You have participated in an investigational drug study within 4 weeks of entering this study
- Your weight is not within a specific range for the study
- You have a history of GI problems like a gastric ulcer
- You have had gastric or intestinal surgery
- You have had abdominal or chest surgery
- You are currently abusing drugs or alcohol or have a history of abuse
- You have a history of psychiatric disorders
- You are a smoker or have smoked during the last year
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Registry information
Important dates
- Study start
- 2004
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Oct 15, 2007
- Registry last updated
- Jun 11, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
NCT05208268
Digestive System Diseases, Duodenal Diseases
Bucheon-si, Gyeongji-do, South Korea
View Trial DetailsEfficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
NCT00787254
Digestive System Diseases, Duodenal Diseases
Kasugai-shi, Aichi-ken, Japan
View Trial DetailsDose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
NCT00284908
Deglutition Disorders, Digestive System Diseases
San Antonio, Texas, United States
View Trial DetailsEffect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
NCT00239551
Digestive System Diseases, Duodenal Diseases
Atlanta, Georgia, United States
View Trial Details